Coordinating Center to accelerate translating heart, lung, and blood therapies to patients
Official title: Coordinating Center for the NHLBI Catalyze Program
Funded at Research Triangle Institute · NIH-11552364 · Data updated 2026-11-12
A national program to help move promising heart, lung, and blood therapies from the lab into real-world patient care more quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project start | September 15, 2020 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $9,893,322 |
| NIH project number | 4OT2HL157844-02 |
| Project ID | NIH-11552364 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with heart, lung, blood, or sleep disorders may benefit from translational advances supported by this program.
✕Less likely to help
The program itself does not test therapies in patients; benefits depend on subsequent products advancing to clinical trials.
What this research studies
This program centers on providing mentoring, guidance, and technical support to researchers developing new therapies and platform technologies for heart, lung, blood, and sleep diseases. It aims to streamline discovery through IND-enabling studies and accelerate translation into clinical use. By merging past NHLBI translational practices, it intends to shorten the time from bench to bedside and improve patient access to innovative treatments.
Why it matters
Potential benefit: If successful, patients could see faster access to novel therapies and improved treatment options for heart, lung, blood, and sleep conditions.
How similar studies have gone: Previous NHLBI translational programs laid groundwork and informed this catalytic model, with ongoing impact on therapy development.
Where this research is happening
-
Research Triangle Institute
Research Triangle Park, United States Active
Researchers
- Principal investigator: Severynse-Stevens, Diana M — Research Triangle Institute
- Study coordinator: Severynse-Stevens, Diana M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.